Native polymeric forms of properdin selectively bind to targets and promote activation of the alternative pathway of complement

Abstract Properdin, a positive regulator of the complement system, has recently been reported to bind to certain pathogenic microorganisms, to early or late apoptotic and necrotic cells, and to particular live human cell lines, thus providing a platform for de novo convertase assembly and complement activation. These studies, with some contradictory results, have been carried out with purified properdin, which forms a series of oligomers of a ∼53,000 Mr subunit, assembling into dimers (P2 ), trimers (P3 ), tetramers (P4 ) and higher forms (Pn ). The Pn forms have been shown to likely be an artefact of purification that results from procedures including freeze-thawing of properdin. In this study we isolated the individual natural forms of properdin (P2 , P3 , and P4 ) and separated them from the Pn forms present in purified frozen properdin using ion exchange and/or size exclusion chromatography. We analyzed the ability of each form to bind to live or necrotic Jurkat and Raji cells, rabbit erythrocytes (ER ), and zymosan by FACS analysis. While the unseparated properdin and the purified Pn forms bound to all the surfaces except ER , the physiological P2 –P4 forms specifically bound only to zymosan and to necrotic nucleated cells. Our results indicate that aggregated Pn present in unseparated properdin may bind non-specifically to some surfaces and should be separated before analysis in order to obtain meaningful results. Finally, we have determined for the first time that the physiological forms of human properdin can selectively recognize surfaces and enhance or promote complement activation, which is in agreement with the reported role for properdin as a complement initiator.